CVS — CVS HEALTH CORP
Health Care · Healthcare Plans
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying CVS?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
Of 3 tracked investors who changed their CVS position last quarter, 3 bought and 0 sold (100% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 55/100 in a Squeeze regime). 1 congressional purchase, 0 sales disclosed in the last 6 months.
- +3 tracked investors added or increased positions last quarter (Paul Tudor Jones, Steve Cohen, Ray Dalio)
- +5 tracked investors reported holding CVS at their latest filing
- +Macro Health is 52/100 in a Squeeze regime — historically acceptable for Health Caresource
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 8/4/2026.
About CVS HEALTH CORP (CVS)
CVS HEALTH CORP (CVS) appears in the most recent 13F filings of 5 tracked institutional investors. CVS HEALTH CORP is classified in the Health Care sector (Healthcare Plans industry). The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $1.0B. Across recent filings, tracked investors recorded 6 new positions, 0 increased, 0 reduced, and 1 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in CVS
How many top investors track CVS
A small number of top investors own this.
CVS Ownership Composition
How CVS HEALTH CORP is held across tracked investor types, based on reported 13F positions.
- Other98.6%
- Hedge Funds1.4%
Tracked investors reporting CVS
- Ken GriffinMar 31, 2026Citadel AdvisorsShares10.1MValue$725.3M% Portfolio0.12%
- Izzy EnglanderMar 31, 2026Millennium ManagementShares1.8MValue$126.8M% Portfolio0.05%
- Steve CohenMar 31, 2026Point72 Asset ManagementShares190.1KValue$13.7M% Portfolio0.02%
- Ray DalioMar 31, 2026Bridgewater AssociatesShares618.4KValue$44.4M% Portfolio0.20%
- Paul Tudor JonesMar 31, 2026Tudor Investment CorpShares811.2KValue$58.3M% Portfolio0.11%
Recent activity
- $47.5MFeb 17, 2026
- $58.3MMay 15, 2026
- New$229.2MFeb 17, 2026
- New$13.7MMay 15, 2026
- New$44.4MMay 15, 2026
- Sold$0(-100.00%)Feb 13, 2026
- New$90MNov 13, 2025
Frequently asked questions
- How many institutional investors hold CVS?
- 5 tracked institutional investors disclosed a position in CVS (CVS HEALTH CORP) in their most recent 13F filing.
- Who is the largest institutional holder of CVS?
- Ken Griffin, Citadel Advisors, holds the largest disclosed position in CVS, valued at $1.0B.
- Did institutional ownership of CVS increase or decrease?
- Across recent 13F filings, tracked investors recorded 6 new positions, 0 increased, 0 reduced, and 1 fully exited CVS.
- What sector is CVS in?
- CVS HEALTH CORP is classified in the Health Care GICS sector, Healthcare Plans industry.
- Where does this CVS ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.